Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions

Neuropsychopharmacology

Volumn 24, Issue 3, 2001, Pages 253-266

  Stine, Christy D ^a   Lu, Wenxiao ^a   Wolf, Marina E ^a  

^a FUHS The Chicago Medical School   (United States)

Author keywords

Alternative splicing; AMPA receptors; In situ hybridization; Nucleus accumbens; Prefrontal cortex; Schizophrenia

Indexed keywords

AMPA RECEPTOR; EXCITATORY AMINO ACID; MESSENGER RNA; OLIGONUCLEOTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACIDS; HIPPOCAMPUS; IBOTENIC ACID; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 0035130551     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00212-8     Document Type: Article

References (111)

1. Editing for an AMPA receptor subunit RNA in prefrontal cortex and schizophrenia in Alzheimer's disease, Huntington's disease and schizophrenia
2. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
3. Subunit composition, kinetic, and permeation properties of AMPA receptors in single neocortical nonpyramidal cells
4. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy
5. Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients
6. Is there a neuroanatomic basis for schizophrenia? An old question revisited
7. Increased interaction of dopamine-immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the postweanling period
8. Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel
9. Molecular cloning and functional expression of glutamate receptor subunit genes
10. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: An electrochemical study in the adult rat
11. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers
12. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold
13. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease
14. Hippocampal afferents to the rat prefrontal cortex: Synaptic targets and relation to dopamine terminals
15. Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis- and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment
16. Cellular localization and laminar distribution of AMPA glutamate receptor subunit mRNAs and proteins in the rat cerebral cortex
17. The glutamatergic dysfunction hypothesis for schizophrenia
18. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia
19. Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats
20. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons
21. γ-glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naïve patients with schizophrenic disorders
22. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: A reverse transcriptase-polymerase chain reaction (RT-PCR) study
23. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain
24. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment
25. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics
26. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients
27. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
28. 3H]AMPA binding in postmortem human brain from psychotic subjects and controls: Increases in caudate nucleus associated with suicide
29. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS
30. The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia
31. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory
32. Gating of information flow within the limbic system and the pathophysiology of schizophrenia
33. Disruption of latent inhibition in rats with postnatal hippocampal lesions
34. Organization of the projections from the subiculum to the ventral striatum in the rat: A study using anterograde transport of Phaseolus vulgaris-leucoagglutinin
35. GABAergic neurons with AMPA GluR1 and GluR2/3 immunoreactivity in the rat striate cortex
36. Clozapine improves dizocilpine-induced delayed alternation impairment in rats
37. Clozapine and haloperidol differentially affect AMPA and kainite receptor subunit mRNA levels in rat cortex and striatum
38. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
39. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia
40. 2+ permeability of KA-AMPA-gated channels depends on subunit composition
41. Cloned glutamate receptors
42. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo
43. The postnatal development of AMPA receptor subunits in the basal ganglia of the rat
44. Amelioration of negative symptoms in schizophrenia by glycine
45. Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat
46. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin
47. Excitatory amino acid pathway from the hippocampus to the prefrontal cortex. Contribution of AMPA receptors in hippocampo-prefrontal cortex transmission
48. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression
49. Development of the dopaminergic innervation in the prefrontal cortex of the rat
50. Rat hippocampal kindling induces changes in the glutamate receptor mRNA expression patterns in dentate granule neurons
51. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde- and retrograde-horseradish peroxidase study
52. A family of AMPA-selective glutamate receptors
53. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
54. 3H]Amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: Minimal changes in postmortem brains of chronic schizophrenics
55. Effects of haloperidol on CSF glutamate levels in drug-naïve schizophrenic patients
56. AMPA receptor subunits expressed by single Purkinje cells
57. Correlation between kinetics and RNA splicing of α-amino-3-hydrdoxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons
58. Effects of pentylenetetrazol kindling on glutamate receptor genes expression in the rat hippocampus
59. Seizure-related changes in the glutamate R2 and R5 receptor genes expression in the rat hippocampal formation
60. The functional architecture of the prefrontal cortex and schizophrenia
61. Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia
62. Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage
63. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol
64. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia
65. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine
66. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat
67. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage
68. In situ hybridization histochemistry: A new method for processing material stored for several years
69. A ribonuclease-resistant method of in situ hybridization histochemistry in rat brain tissue
70. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex
71. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex
72. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex
73. Long-term potentiation - A decade of progress?
74. AMPA glutamate receptor subunits are differentially distributed in rat brain
75. Glutamate receptor expression in schizophrenic brain
76. Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing
77. A molecular determinant for submillisecond desensitization in glutamate receptors
78. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains
79. Glutamate receptor dysfunction and schizophrenia
80. Locally evoked potentials in slices of the rat nucleus accumbens: NMDA and non-NMDA receptor mediated components and modulation by GABA
81. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: An integration of behavioural, electrophysiological and anatomical data
82. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain
83. Alterations of the GluR-B AMPA receptor subunit Flip/Flop expression in kainate-induced epilepsy and ischemia
84. Glutamate receptors in dysplasic cortex: An in situ hybridization and immunocytochemistry study in rats with prenatal treatment with methylazoxymethanol
85. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs
86. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood
87. The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain
88. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats
89. Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats
90. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other
91. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
92. GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons
93. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons
94. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
95. Flip and flop: A cell-specific functional switch in glutamate-operated channels of the CNS
96. A direct projection from Ammon's horn to prefrontal cortex in the rat
97. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons
98. Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic Seroquel (quetiapine fumarate)
99. Regional distribution and developmental changes of GluR1-Flop protein revealed by monoclonal antibody in rat brain
100. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
101. D-serine added to antipsychotics for the treatment of schizophrenia
102. Quantitative localization of AMPA/kainate and kainate glutamate receptor subunit immunoreactivity in neurochemically identified subpopulations of neurons in the prefrontal cortex of the Macaque monkey
103. Postnatal maturation of GABA-immunoreactive neurons of rat medial prefrontal cortex
104. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: Behavioral and in vivo microdialysis studies
105. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions
106. Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions
107. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground
108. Schizophrenia and the parvalbumin-containing class of local circuit neurons
109. Glutamate receptor expression in rat striatum: Effect of deafferenntation
110. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations